In this report, we performed a comprehensive methylation study of the TP53-centered tumor suppressor network by studying DNA methylation of miR-34a and DAPK1 in addition to miR-34b/c in a representative cohort of CLL. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.